140 related articles for article (PubMed ID: 454517)
1. Decrease of 3-methylhistidine and increase of NG,NG-dimethylarginine in the urine of patients with muscular dystrophy.
Inoue R; Miyake M; Kanazawa A; Sato M; Kakimoto Y
Metabolism; 1979 Aug; 28(8):801-4. PubMed ID: 454517
[TBL] [Abstract][Full Text] [Related]
2. [Urinary excretion of methylamino acids in myogenic and neurogenic muscular atrophy (author's transl)].
Inoue R
Rinsho Shinkeigaku; 1980 Jul; 20(7):510-5. PubMed ID: 7460420
[No Abstract] [Full Text] [Related]
3. 3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease.
McKeran RO; Halliday D; Purkiss P; Royston P
J Neurol Neurosurg Psychiatry; 1979 Jun; 42(6):536-41. PubMed ID: 469561
[TBL] [Abstract][Full Text] [Related]
4. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F
Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577
[TBL] [Abstract][Full Text] [Related]
5. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
Warnes DM; Tomas FM; Ballard FJ
Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447
[TBL] [Abstract][Full Text] [Related]
6. Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
McKeran RO; Halliday D; Purkiss P
J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):979-81. PubMed ID: 591977
[TBL] [Abstract][Full Text] [Related]
7. Human muscular dystrophy: elevation of urinary dimethylarginines.
Lou MF
Science; 1979 Feb; 203(4381):668-70. PubMed ID: 760213
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of 3-methylhistidine and creatine in carriers of Duchenne muscular dystrophy.
Maskrey P; Harris CI; Milne G; Lane RJ; Pennington RJ
Clin Chim Acta; 1979 May; 94(1):89-91. PubMed ID: 455721
[TBL] [Abstract][Full Text] [Related]
9. Urinary 3-methylhistidine and urinary 3-methylhistidine/creatinine ratio in Duchenne-muscular dystrophy in hemizygotes and in gene-carriers.
László A; Klujber L
Acta Paediatr Hung; 1984; 25(4):339-41. PubMed ID: 6525307
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of dimethylarginines in premature infants.
Yudkoff M; Nissim I; Pereira G; Segal S
Biochem Med; 1984 Oct; 32(2):242-51. PubMed ID: 6508772
[TBL] [Abstract][Full Text] [Related]
11. Excretion of total and muscular N tau-methylhistidine and creatinine in muscle diseases.
Röthig HJ; Bernhardt W; Afting EG
Muscle Nerve; 1984 Jun; 7(5):374-9. PubMed ID: 6738575
[TBL] [Abstract][Full Text] [Related]
12. 3-methylhistidine excretion in myotonic dystrophy.
Griggs RC; Moxley RT; Forbes GB
Neurology; 1980 Dec; 30(12):1262-7. PubMed ID: 7192806
[TBL] [Abstract][Full Text] [Related]
13. Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion.
Ballard FJ; Tomas FM; Stern LM
Clin Sci (Lond); 1979 Apr; 56(4):347-52. PubMed ID: 477220
[TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown.
Elia M; Carter A; Bacon S; Winearls CG; Smith R
Br Med J (Clin Res Ed); 1981 Jan; 282(6261):351-4. PubMed ID: 6780020
[TBL] [Abstract][Full Text] [Related]
15. Content of methylhistidines in normal and pathological human skeletal muscles.
Mussini E; Cornelio F; Dworzak F; Cotellessa L; Morandi L; Colombo L; De Ponte G; Marcucci F
Muscle Nerve; 1983; 6(6):423-9. PubMed ID: 6621612
[TBL] [Abstract][Full Text] [Related]
16. Free amino acids in the plasma and urine of dogs from birth to senescence.
Blazer-Yost B; Jezyk PF
Am J Vet Res; 1979 Jun; 40(6):832-8. PubMed ID: 475135
[TBL] [Abstract][Full Text] [Related]
17. Decrease in urinary excretion of 3-methylhistidine by patients with Duchenne muscular dystrophy during glucocorticoid treatment.
Kawai H; Adachi K; Nishida Y; Inui T; Kimura C; Saito S
J Neurol; 1993; 240(3):181-6. PubMed ID: 8482992
[TBL] [Abstract][Full Text] [Related]
18. [Urinary 3-methylhistidine excretion in children with neuromuscular diseases].
Kumagai T; Takeuchi T; Hara K; Miyazaki S; Riko T; Shionoya T; Komatsu K; Mizutani N; Watanabe K
No To Hattatsu; 1984 Nov; 16(6):445-9. PubMed ID: 6518118
[No Abstract] [Full Text] [Related]
19. Characteristic clinical findings in some neurogenic myopathies and in some myogenic myopathies causing muscular weakness, hypotonia and atrophy in infancy and early childhood.
Gamstorp I
Birth Defects Orig Artic Ser; 1971 Feb; 7(2):72-81. PubMed ID: 5173129
[TBL] [Abstract][Full Text] [Related]
20. [Urinary amino acids in progressive muscular dystrophy and amyotonia congenita].
BAUZA C
Arch Pediatr Urug; 1959 Dec; 30():749-55. PubMed ID: 13797772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
